Corporate Committee

The goal of the Corporate Committee is to create an organized way to explore collaborative opportunities. Our intent is for the Corporate Committee to work together with PHA Canada to find solutions on a variety of issues such as improving diagnosis, increasing education, raising public visibility of PH, and assuring access to medication for all patients in Canada.

We would like to thank those companies who, by participating in the Corporate Committee, are fulfilling a special responsibility to the PH community.

Structure

In addition to its corporate members, the PHA Canada Corporate Committee includes representation from the PHA Canada Board of Directors, Medical Advisory Board, and Executive Director.

Chair:

Bayer (term ends Fall 2016)

Current Members:

  • Actelion 
  • Bayer
  • GSK (incoming Chair for 2017)
  • McKesson
  • Pfizer
  • Shoppers Drug Mart Specialty Health
  • United Therapeutics

BOARD LIAISON(S): Sanjay Mehta & Roberta Massender

MEDICAL ADVISORY LIASON: Sanjay Mehta

STAFF LIAISON: Jamie Myrah


Subscribe

Get the latest on PH treatments, community events and more when you subscribe to our newsletter

ImagineCan_Accreditation_Trustmark_ENGFR_WHT-FNL_white.png